Mild nausea, stomach upset, constipation, or fatigue can occur, especially early on
Changes in glucose metabolism and glycemic status with once-weekly subcutaneous semaglutide 2.4 mg among participants with prediabetes in the STEP program
(28) GLP-1 Agonists and Surgical Outcomes Pre-Clinical Studies Liu et al
Results vary by age, skin quality, and number of treatments
At Mullally Sports and Family Medicine in Crown Point, IN, our professional team monitors each patients progress and provides personalized guidance to help support safe, realistic, and sustainable weight loss with semaglutide GLP-1 treatment
Conversion at 10mg/mL At 10mg/mL, each unit on your syringe delivers 0.10mg (100 micrograms)